Event Type
Disclosure
Mandatory
Variant
8-K
Entry into a Material Definitive Agreement On October 27, 2025, Calidi Biotherapeutics, Inc. (the “Company”) entered into that certain Stock Repurchase Agreemen
Termination of Material Agreement Effective upon execution of the Material Purchase Agreement described in Item 1.01 above, the parties’ Intellectual Property A
Completion of Acquisition or Disposition of Assets The information in Item 1.01 above is incorporated herein by reference. Item 9.01 Financial Statements and Ex